This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Praxair Supports Appropriated Extension Of Federal Helium Program As Only Viable Solution Before Funding Expires

As a longtime participant in the Federal Helium Program, Praxair (NYSE:PX) today called on Congress to extend funding to the critical, revenue-positive program through Fiscal Year 2014. Funding for the Federal Helium Program run by the U.S. Department of the Interior’s Bureau of Land Management (BLM) is set to expire on October 7, 2013, which will force the suspension of operations at the Federal Helium Reserve and restrict market access to nearly 30% of the world’s helium supply.

Authorities at the BLM issued notification to helium refiners and others who have contracts related to the Reserve, including Praxair, that without an appropriation by the end of September 2013, they will begin the process of shutting down Reserve operations. The BLM estimates that a shuttered Federal Helium Reserve will cost the American taxpayer as much as $500,000 per day in lost revenue and incurred expense, which is a tiny fraction of the impact it will have on the U.S. and global economies.

“The continued operation of the Federal Helium Reserve has substantial implications for the global helium market and for the medical, electronics and automotive industries whose applications such as MRIs, fiber optics and airbags depend on a reliable supply of helium,” said Dr. Amer Akhras, general manager, Helium and Rare Gases, Praxair, Inc.

Praxair has actively worked with longtime partners at the BLM and with Congress to preempt any potential shutdown. While supportive of efforts taken by the House and the Senate to identify efficient and appropriate opportunities to continue the program, the significant differences in their approaches make a legislative solution unlikely before the BLM’s deadline at the end of September.

“An appropriation is now an absolute necessity in order to avoid global market disruption, assure continued access to helium, and ensure that the current, revenue-positive program continues to meet American industry and taxpayer needs,” continued Akhras.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs